Term
|
Definition
- neurotransmitter in periphery which mediates the effects of sympathetatic stimulation;
- not as potent as Epi; reduces renal and hepatic blood flow
|
|
|
Term
|
Definition
- hypotension
- local vasoconstriction
- nasal decongestion
-paroxymal atrial tachycardia |
|
|
Term
|
Definition
-alpha agonist; reduces renal/hepatic/muscle blood flow- vessels have a lot of alpha receptors in arterioles and NE produces vasoconstriction (reduce the flow of blood through these tissues).
Increases MABP; Reflex bradycardia
|
|
|
Term
|
Definition
- in the nose there are blood vessels that are subject to vasodilation. When giving a drug that causes vasodilation, you'll get nasal stuffiness. Histamine acts on H1 receptors and produces vasodilation. An alpha agonist activity will cause vasoconstriction (reduction in the blockage of the nasal mucosal blood vessels). Nasal preparations contain sympathomimetics |
|
|
Term
|
Definition
- an alpha agonist will combat paroxysmal atrial tachycardia b/c it increases PS stimulation to the heart by causing vasoconstriction;
- it has ability to produce reflex bradycardia
|
|
|
Term
|
Definition
- tissue necrosis (slough) due to alpha stimulation (infuse centrally, high on limb)
- hyperthyroidism
- sensitization of myocardium
- contraction of gravid uterus, NOT to use in PG |
|
|
Term
|
Definition
NE is a very potent vasoconstrictor so it
can produce tissue necrosis, when it’s
administered or applied to an end organ
|
|
|
Term
|
Definition
non-selective beta agonist |
|
|
Term
|
Definition
- vascular and nonvascular smooth muscle
beta-2 stimulation;
- metabolic: hyperglycemia, FFA release;
- cardiac stimulation;
- bronchoconstriction |
|
|
Term
Dopamine low dose effects |
|
Definition
Dopamine agonist effects:
- increases renal blood flow (interacts with
dopamine receptors in renal vasculature)
- increases glomerular filtration;
- increases sodium excretion |
|
|
Term
Dopamine moderate dose effects |
|
Definition
Dopamine agonist plus beta-1 plus IAS action:
- increased cardiac output
- increased systolic BP
- increased coronary blood flow
- no change in tissue peripheral
resistance or diastolic BP |
|
|
Term
Dopamine high dose effects |
|
Definition
Dopamine + beta-1 + indirect (can promote the release of NE) + alpha:
- increased PR, increase in HR; the heart is pumping against the increase in PR
- renal vasoconstriction, as you see alpha
effects in SC;
- indirect action, promoting the release
of NE from adrenergic nerves
|
|
|
Term
|
Definition
- shock by continuous infusion, superior to
NE b/c NE produces vasoconstriction, it’s
going to produce decrease in heart rate.
- increases blood flow to kidneys &
enhances glomerular filtration |
|
|
Term
Dopamine- adverse effects |
|
Definition
Overdose- similar to those due to
sympathetic stimulation
-nausea, hypertension, arrhythmia |
|
|
Term
|
Definition
- selective beta 1 agonist. It is a cardiac stimulant, synthetic catecholamine, Isoproterenolol derivative.
- produces cardiac beta 1 effects, slight alpha and beta 2 activity
- made up of 2 isomers w/ either beta 2 or alpha agonism.
As you increase the dose, you lose the potential to produce
a + iontropic effect w/o producing a chronotropic effect.
So at at high doses it resembles ISO .
|
|
|
Term
|
Definition
- improved over other catecholamines; less tachycardia,
increase in systolic BP, less effect on oxygen demand,
no decrease in cardiac efficiency. It increases Systolic
BP b/c it increases CO, but less tachycardia.
It will NOT cause a decrease in cardiac efficiency
b/c this is due to beta 2 agonists activity.
|
|
|
Term
Comparison at equipotent
beta-1 doses |
|
Definition
Isoproterenol has NO alpha-1 effects
but has a lot of beta-2 agonist activity (+5)
NE has a lot of alpha-1 effects (+5)
but no beta-2 effects
Dobutamine has the same low
alpha-1 and beta-2 effects (+1) |
|
|
Term
|
Definition
-some type of shock w/ oliguria |
|
|
Term
Dobutamine adverse effects |
|
Definition
- cathecolamine adverse effects; miocardial
effects with halogenated hydrocarbons,
cardiac arrhythmias, tachycardia
(approx. 10%- like ISO) |
|
|
Term
|
Definition
- given IV causes a reflex bradycardia
b/c ofit’s alpha agonist activity.
No beta 1 agonist activity is observed
when given IV
|
|
|
Term
NE, EPI and ISO
In vitro D/R plots
|
|
Definition
Arterial smooth muscle
EPI> NE >>>>> ISO
Bronchial smooth muscle
ISO> EPI >>>>>> NE
Cardiac Inotropism
ISO > EPI = NE
|
|
|
Term
EPI, NE and ISO D/R plots
w/ & w/o Antagonist |
|
Definition
Arterial smooth muscle
NE=NE + Propanolol >>>>NE + Phentolamine
Bronchial smooth muscle
ISO= ISO +Phentolamine>>>>ISO + Propanolol
Cardiac Inotropism
NE=NE+ Phentolamine>>>NE+Propanolol |
|
|
Term
|
Definition
In arterial smooth muscle Epi is much more
potent than NE and NE is way more potent
than ISO, because ISO has no alpha agonist
activity. EPI is the most potent of those catecholamines so its ED50 would be much
smaller than that of NE.
|
|
|
Term
|
Definition
- the most potent beta agonist;
-not taken up into adrenergic nerves
(reuptake is not important)
|
|
|
Term
|
Definition
- refers to force of attraction; + iontropism increases the force
of attraction and - iontropism decreases the force of attraction.
So administration of a beta 1 agonist, normally you don’t have
any reflexes acting, drop it right on the heart, you'll have
a + ionitropic effect. Administer a muscarinic agonist drop
it right on the heart will cause a - iontropic effect, b/c
it’s going to reduce the contractile response |
|
|
Term
|
Definition
+ speeds up, - chronotropism it slows down. A drug which
has beta 1 agonist activity put it right on the heart it
speeds up the heart, it’s + chronotopism. A drug
put on the heart that slows it down, is -
chronotropism. Administration of an adrenergic neuron
blocker in vivo would exibit - chronotropism
|
|
|
Term
|
Definition
-given IV will cause reflex bradycardia and hypertension
|
|
|
Term
Adrenergic neuron blocker |
|
Definition
- causes a reduction in sympathetic stimulation |
|
|
Term
|
Definition
- produce an increase in heart rate
and contraction |
|
|
Term
NE
NE + propanolol
NE + phentolamine
in arterial smooth muscle |
|
Definition
NE gives the same D/R plot as NE + propanolol (beta blocker), b/c NE doesn’t bind to beta receptors in the arterioles, to
give you contraction of the arterial smooth muscle.
NE + phentolamine (alpha receptor antagonist) will give a big
shift in the dose response curve to the right. So the EC50 will
be increased a lot by phentolamine but not by propanolol.
NE works on alpha receptors in the arterial smooth muscle.
|
|
|
Term
|
Definition
alpha receptor antagonist |
|
|
Term
|
Definition
|
|
Term
ISO
ISO + Phentolamine
ISO + Propanolol on
bronchial smooth muscle |
|
Definition
On bronchial smooth muscle you have beta
2 receptors, and ISO will produce relaxation
of bronchial smooth muscle. ISO plus
phentolamine will not give you a shift
in D/R plot. ISO plus propanolol will give
a big shift in D/R plot to the right.
|
|
|
Term
NE
NE + Phentolamine
NE + Propanolol
Cardiac Inotropism |
|
Definition
NE plus phentolamine gives no shift in D/R
plot but NE plus propanol gives you a rightward shift in D/R plot. Cardiac inotropism is
mediated via an increase in beta 1 receptor stimulation. Propanolol results in a rightward
shift in D/R plot b/c it is blocking the receptor
that NE needs to interact to produce an
incease in heart rate
|
|
|